Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 4
1975 4
1976 6
1977 4
1978 10
1979 9
1980 7
1981 4
1982 9
1983 13
1984 23
1985 22
1986 40
1987 25
1988 51
1989 55
1990 68
1991 47
1992 65
1993 82
1994 121
1995 103
1996 85
1997 131
1998 124
1999 127
2000 126
2001 220
2002 208
2003 214
2004 247
2005 196
2006 195
2007 184
2008 138
2009 168
2010 197
2011 164
2012 162
2013 167
2014 196
2015 205
2016 240
2017 223
2018 195
2019 188
2020 247
2021 254
2022 239
2023 289
2024 195
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,914 results

Results by year

Filters applied: . Clear all
Page 1
Colon cancer.
Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, de Braud F, Wils J. Labianca R, et al. Crit Rev Oncol Hematol. 2010 May;74(2):106-33. doi: 10.1016/j.critrevonc.2010.01.010. Crit Rev Oncol Hematol. 2010. PMID: 20138539 Review.
Colon cancer is one of the leading tumours in the world and it is considered among the big killers, together with lung, prostate and breast cancer. In the recent years very important advances occurred in the field of treatment of this frequent disease: adjuvant chemotherap …
Colon cancer is one of the leading tumours in the world and it is considered among the big killers, together with lung, prostate and …
Classification and Pathology of Lung Cancer.
Zheng M. Zheng M. Surg Oncol Clin N Am. 2016 Jul;25(3):447-68. doi: 10.1016/j.soc.2016.02.003. Surg Oncol Clin N Am. 2016. PMID: 27261908 Review.
Advancement in the understanding of lung tumor biology enables continued refinement of lung cancer classification, reflected in the recently introduced 2015 World Health Organization classification of lung cancer. ...Neuroendocrine tumors are divided into typ …
Advancement in the understanding of lung tumor biology enables continued refinement of lung cancer classification, reflected i …
Squamous cell lung cancer: Current landscape and future therapeutic options.
Lau SCM, Pan Y, Velcheti V, Wong KK. Lau SCM, et al. Cancer Cell. 2022 Nov 14;40(11):1279-1293. doi: 10.1016/j.ccell.2022.09.018. Epub 2022 Oct 20. Cancer Cell. 2022. PMID: 36270277 Free article. Review.
Squamous cell lung cancers (lung squamous cell carcinomas [LUSCs]) are associated with high mortality and a lack of therapies specific to this disease. ...For example, the recognition that alterations in KEAP1-NFE2L2 in LUSCs affected antitumor immune respons …
Squamous cell lung cancers (lung squamous cell carcinomas [LUSCs]) are associated with high mortality and a lack of the …
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, Bunn P, Cascone T, Chaft J, Chen G, Chou TY, Cooper W, Erasmus JJ, Ferreira CG, Goo JM, Heymach J, Hirsch FR, Horinouchi H, Kerr K, Kris M, Jain D, Kim YT, Lopez-Rios F, Lu S, Mitsudomi T, Moreira A, Motoi N, Nicholson AG, Oliveira R, Papotti M, Pastorino U, Paz-Ares L, Pelosi G, Poleri C, Provencio M, Roden AC, Scagliotti G, Swisher SG, Thunnissen E, Tsao MS, Vansteenkiste J, Weder W, Yatabe Y. Travis WD, et al. J Thorac Oncol. 2020 May;15(5):709-740. doi: 10.1016/j.jtho.2020.01.005. Epub 2020 Jan 28. J Thorac Oncol. 2020. PMID: 32004713 Free PMC article. Review.
Currently, there is no established guidance on how to process and evaluate resected lung cancer specimens after neoadjuvant therapy in the setting of clinical trials and clinical practice. ...The International Association for the Study of Lung Cancer has an effort t …
Currently, there is no established guidance on how to process and evaluate resected lung cancer specimens after neoadjuvant therapy i …
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.
Niu Z, Jin R, Zhang Y, Li H. Niu Z, et al. Signal Transduct Target Ther. 2022 Oct 5;7(1):353. doi: 10.1038/s41392-022-01200-x. Signal Transduct Target Ther. 2022. PMID: 36198685 Free PMC article. Review.
Lung cancer is the leading cause of cancer-related death across the world. Unlike lung adenocarcinoma, patients with lung squamous cell carcinoma (LSCC) have not benefitted from targeted therapies. ...We also provided some progress of LSCC in epigeneti …
Lung cancer is the leading cause of cancer-related death across the world. Unlike lung adenocarcinoma, patients with lung …
Serotonin Pathway in Cancer.
Balakrishna P, George S, Hatoum H, Mukherjee S. Balakrishna P, et al. Int J Mol Sci. 2021 Jan 28;22(3):1268. doi: 10.3390/ijms22031268. Int J Mol Sci. 2021. PMID: 33525332 Free PMC article. Review.
Several in vitro studies have shown the anticancer effect of 5-HT receptor antagonists in various cancers such as prostate cancer, breast cancer, urinary bladder, colorectal cancer, carcinoid, and small-cell lung cancer. More in vivo studies are needed to assess serotonin' …
Several in vitro studies have shown the anticancer effect of 5-HT receptor antagonists in various cancers such as prostate cancer, breast ca …
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R, Gao J, Cui Q, Wang Q. Xing R, et al. Front Immunol. 2021 Nov 26;12:783236. doi: 10.3389/fimmu.2021.783236. eCollection 2021. Front Immunol. 2021. PMID: 34899747 Free PMC article. Review.
Combining different ICIs may have a synergistical effect attributed to the complementary effects of the two immune checkpoint pathways (CTLA-4 and PD-1/PD-L1 pathways). ...This review aims to summarize the currently reported results and ongoing trials of the ICIs-based …
Combining different ICIs may have a synergistical effect attributed to the complementary effects of the two immune checkpoint pathway …
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region.
Kim DY, Toan BN, Tan CK, Hasan I, Setiawan L, Yu ML, Izumi N, Huyen NN, Chow PK, Mohamed R, Chan SL, Tanwandee T, Lee TY, Hai TTN, Yang T, Lee WC, Chan HLY. Kim DY, et al. Clin Mol Hepatol. 2023 Apr;29(2):277-292. doi: 10.3350/cmh.2022.0212. Epub 2023 Jan 30. Clin Mol Hepatol. 2023. PMID: 36710606 Free PMC article. Review.
Even though the combined use of ultrasound (US) and alpha-fetoprotein (AFP) is recommended for the surveillance of hepatocellular carcinoma (HCC), the utilization of AFP has its challenges, including accuracy dependent on its cut-off levels, degree of liver necroinf …
Even though the combined use of ultrasound (US) and alpha-fetoprotein (AFP) is recommended for the surveillance of hepatocellular …
SWI/SNF-deficient thoraco-pulmonary neoplasms.
Sesboue C, Le Loarer F. Sesboue C, et al. Semin Diagn Pathol. 2021 May;38(3):183-194. doi: 10.1053/j.semdp.2020.12.002. Epub 2021 Jan 12. Semin Diagn Pathol. 2021. PMID: 33451916 Review.
Malignant rhabdoid tumors were the first malignancies linked to deregulation of these complexes with the involvement of SMARCB1 in their development but genetic alterations affect all subunits in other malignancies. In the chest and lung regions, SMARCA4 (BRG1) is the most …
Malignant rhabdoid tumors were the first malignancies linked to deregulation of these complexes with the involvement of SMARCB1 in their dev …
High-grade neuroendocrine carcinoma.
Rossi G, Bisagni A, Cavazza A. Rossi G, et al. Curr Opin Pulm Med. 2014 Jul;20(4):332-9. doi: 10.1097/MCP.0000000000000061. Curr Opin Pulm Med. 2014. PMID: 24811834 Review.
PURPOSE OF REVIEW: This review presents an update on classification, diagnosis and potentially 'drugable' molecular alterations of small cell carcinoma (SCC) and large cell neuroendocrine carcinoma (LCNEC) of the lung. RECENT FINDINGS: The main controversies …
PURPOSE OF REVIEW: This review presents an update on classification, diagnosis and potentially 'drugable' molecular alterations of small cel …
5,914 results